Byram, Hollister To Pay $20M To Settle Pay-For-Promotion Allegations
This article was originally published in The Gray Sheet
Executive Summary
The settlement puts to bed whistleblower allegations that Hollister paid supplier Byram for encouraging ostomy and continence care patients to use Hollister products. Byram allegedly had similar arrangements with other manufacturers, including Coloplast.
You may also be interested in...
US Slams Supplier’s Defense in Kickback Case
The latest government filing in a False Claims Act case involving Coloplast counters the defendants’ argument that the case should be dismissed because the alleged kickbacks fell within the "discount" safe harbor.
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and reports progress on initiatives aimed at improving technology adoption. A schedule of ambitious future timelines has also been published.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.